| Affiliation: | 1. Area of Developmental and Cell Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain;2. Area of Myocardial Pathophysiology, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain;3. Unidad de Investigación Neurovascular, Department of Pharmacology, Faculty of Medicine, Universidad Complutense;4. Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain;5. Immunology Unit, Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona;6. Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillians-Universität München;7. German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany;8. Department of Anesthesiology, Intensive Care, and Pain Medicine, University of Münster, Germany;10. Inserm Unité Mixte de Recherche (UMR) S996, Université Paris-Sud, Laboratory of Excellence in Research on Medication and Innovative Therapeutics, Clamart, France;11. Department of Immunology, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de La Princesa, Madrid, Spain;12. Department of Clinical Pharmacology, Instituto Teófilo Hernando, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain;13. Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands;14. CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain;15. Department of Cardiology, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz, Madrid, Spain;16. Present address: Tisch Cancer Institute, Mount Sinai School of Medicine, New York City, New York, USA;17. Present address: Centro Nacional de Biotecnología, Madrid, Spain |
